was meint ihr zu ILEX ONCOLOGY ?? - 500 Beiträge pro Seite

[vofueman]

Hallo zusammen,

bin seit 1 Woche in ILEX investiert. Wie seht Ihr den
Wert. Ich gehe von einem riesigen Kurspotential aus,
denkt Ihr auch so wie ich??? Die Pipeline ist doch echt
vielversprechend und in diesem Jahr sind vielleicht schon
die ersten Gewinne in Sicht.
Postet doch einfach mal Eure Meinung.

So long

vofueman

[genya]

hast völlig recht, aber rechne nicht mit 100% steigerung innerhalb von 4 Wochen, eher unwahrscheinlich. Schau dir auch Epimmune, GZMO, GZTC, ATIS, Aria, CBMI und Immunex an

[genya]

und natürlich RZYM, Guilford und Medarex

[vofueman]

@genia:

4 Wochen denke ich auch nicht, aber so auf den Rest diesen Jahres
gesehen denke ich mal ist einiges machbar.

Hoffentlich erhält Campath bald die Zulassung, aber ich denke doch
das wir davon ausgehen können.

Wir werden noch viel Spass erleben !!!

so long

vofueman

[winman]

Hi bio-friends,

Ilex wird PLATZEN; wenn "C" die Zulassung bekommt!!!
...also treu bleiben-aber aufpassen!

-gruß WINMAN

[ruebezahl]

Ilex Oncology Joins the Russell 2000-R- Index <ILXO.O>


Ilex Oncology Joins the Russell 2000-R-
Index

SAN ANTONIO--(BUSINESS WIRE)--July 11, 2000--ILEX(TM) Oncology,
Inc. (Nasdaq:ILXO) today announced its inclusion in the newly
rebalanced Russell 2000(R) Index. Index membership, published Monday
by the Frank Russell Company, is based on market capitalization and
remains in place for one year.
"We are pleased to be among the companies added to the Russell
2000 Index, capping a year of exceptional growth in which ILEX has
made significant progress towards becoming a leading oncology-focused
pharmaceutical company," said ILEX President and Chief Executive
Officer Richard Love. "Membership in a major stock index like the
Russell 2000 further enhances our visibility with the investment
community."
Membership in Russell`s 21 U.S. equity indexes - widely used by
investment managers as benchmarks for both passive and active
investment strategies - is determined strictly by market
capitalization rankings, rather than by subjective opinion.
The indexes are rebalanced each year, according to total market
capitalization as of the end of May. The 3,000 largest U.S. stocks
comprise the broad market Russell 3000(R) Index. The largest 1,000 of
those make up the Russell 1000(R) Index, while the remaining 2,000
form the widely used Russell 2000 Index of small cap companies.
About ILEX
ILEX Oncology, Inc. is a drug development company focused
predominantly on the accelerated development of drugs for the
treatment and prevention of cancer. The company does this in two ways:
by advancing a diversified portfolio of anti-cancer drugs through its
ILEX Products subsidiary, and, by offering drug development services
on a contract basis to pharmaceutical and biotech companies through
its ILEX Oncology Services subsidiary. These complementary businesses
draw from the company`s core relationships with international oncology
experts, strategic alliances providing unparalleled access to patient
recruitment for clinical trials, and simultaneous European and US drug
development and approval capabilities.
Certain statements contained herein are "forward-looking"
statements (as such term is defined in the Private Securities
Litigation Reform Act of 1995). Because such statements include risks
and uncertainties, actual results may differ materially from those
expressed or implied by such forward-looking statements. Factors that
could cause actual results to differ materially from those expressed
or implied by such forward-looking statements include, but are not
limited to, the early stage of ILEX`s compounds under development;
risks in technology and product development; failure to successfully
complete clinical trials; failure to receive market clearance from
regulatory agencies; dependence on third parties and partners and
those risks described in ILEX`s Form S-3 filed March 8, 2000
(Commission file No. 333-32000), and ILEX`s Annual Report on Form 10-K
for the year ended December 31, 1999, and in other filings made by
ILEX with the SEC. ILEX disclaims any obligation to update these
forward-looking statements.
For more information on ILEX, go to http://www.ilexoncology.com on
the World Wide Web. More information on the Russell 2000 Index can be
found at http://www.russell.com.